- Home
- TLSI vs SHMD Comparison
TLSI vs SHMD Comparison
Compare TLSI & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- SHMD
- Stock Information
- Founded
- TLSI 2010
- SHMD 1864
- Country
- TLSI United States
- SHMD Germany
- Employees
- TLSI N/A
- SHMD N/A
- Industry
- TLSI Medical Specialities
- SHMD
- Sector
- TLSI Health Care
- SHMD
- Exchange
- TLSI Nasdaq
- SHMD Nasdaq
- Market Cap
- TLSI 124.9M
- SHMD 144.3M
- IPO Year
- TLSI N/A
- SHMD N/A
- Fundamental
- Price
- TLSI $4.69
- SHMD $2.58
- Analyst Decision
- TLSI Strong Buy
- SHMD
- Analyst Count
- TLSI 6
- SHMD 0
- Target Price
- TLSI $11.75
- SHMD N/A
- AVG Volume (30 Days)
- TLSI 36.4K
- SHMD 51.8K
- Earning Date
- TLSI 11-14-2024
- SHMD 02-25-2025
- Dividend Yield
- TLSI N/A
- SHMD N/A
- EPS Growth
- TLSI N/A
- SHMD 1309.32
- EPS
- TLSI N/A
- SHMD 1.07
- Revenue
- TLSI $26,891,000.00
- SHMD $99,752,404.00
- Revenue This Year
- TLSI $60.96
- SHMD N/A
- Revenue Next Year
- TLSI $53.65
- SHMD N/A
- P/E Ratio
- TLSI N/A
- SHMD $2.30
- Revenue Growth
- TLSI 67.90
- SHMD N/A
- 52 Week Low
- TLSI $3.50
- SHMD $1.98
- 52 Week High
- TLSI $10.42
- SHMD $6.13
- Technical
- Relative Strength Index (RSI)
- TLSI 51.68
- SHMD N/A
- Support Level
- TLSI $4.72
- SHMD N/A
- Resistance Level
- TLSI $5.32
- SHMD N/A
- Average True Range (ATR)
- TLSI 0.31
- SHMD 0.00
- MACD
- TLSI 0.01
- SHMD 0.00
- Stochastic Oscillator
- TLSI 47.52
- SHMD 0.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).